Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

Annals of Oncology : Official Journal of the European Society for Medical Oncology
Barry IacopettaTP53-CRC Collaborative Group

Abstract

Loss of TP53 function through gene mutation is a critical event in the development and progression of many tumour types including colorectal cancer (CRC). In vitro studies have found considerable heterogeneity amongst different TP53 mutants in terms of their transactivating abilities. The aim of this work was to evaluate whether TP53 mutations classified as functionally inactive (< or=20% of wildtype transactivation ability) had different prognostic and predictive values in CRC compared with mutations that retained significant activity. TP53 mutations within a large, international database of CRC (n = 3583) were classified according to functional status for transactivation. Inactive TP53 mutations were found in 29% of all CRCs and were more frequent in rectal (32%) than proximal colon (22%) tumours (P < 0.001). Higher frequencies of inactive TP53 mutations were also seen in advanced stage tumours (P = 0.0003) and in tumours with the poor prognostic features of vascular (P = 0.006) and lymphatic invasion (P = 0.002). Inactive TP53 mutations were associated with significantly worse outcome only in patients with Dukes' stage D tumours (RR = 1.71, 95%CI 1.25-2.33, P < 0.001). Patients with Dukes' C stage tumours appeared to gain a ...Continue Reading

References

Dec 1, 2000·Nature·B VogelsteinA J Levine
Mar 21, 2002·Nature Reviews. Cancer·T Soussi, C Béroud
Sep 7, 2002·International Journal of Cancer. Journal International Du Cancer·Barry Iacopetta
Mar 6, 2003·Human Mutation·Anne-Lise Børresen-Dale
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Shunsuke KatoChikashi Ishioka
Jul 16, 2004·Journal of Cellular Physiology·Manuela MigliavaccaAntonio Russo
Sep 1, 2005·Genes & Development·Jean-Christophe BourdonDavid P Lane
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio RussoUNKNOWN TP53-CRC Collaborative Study Group

❮ Previous
Next ❯

Citations

Sep 11, 2012·Surgery Today·Takashi AkiyoshiToshiaki Watanabe
Jan 21, 2009·Nature Clinical Practice. Gastroenterology & Hepatology·Rachel S MidgleyDavid J Kerr
Sep 25, 2009·Nature Reviews. Cancer·Daniel MenendezMichael A Resnick
Jun 17, 2010·Nature Reviews. Clinical Oncology·Charles FertéJean-Charles Soria
Apr 22, 2009·The Pharmacogenomics Journal·A S StrimpakosM W Saif
Mar 20, 2010·Cold Spring Harbor Perspectives in Biology·Ana I Robles, Curtis C Harris
Dec 17, 2008·Cancer Research·Wooin LeeWael El-Rifai
Jun 7, 2013·BMC Cancer·Arantza Fariña SarasquetaHans Morreau
Feb 4, 2014·Virchows Archiv : an International Journal of Pathology·Xavier Sagaert
Apr 15, 2011·Journal of Biomedicine & Biotechnology·Lucia MiglioreFabio Coppedè
Mar 7, 2008·International Journal of Colorectal Disease·M VidaurretaA Torres
May 30, 2014·Expert Review of Gastroenterology & Hepatology·Fabio Coppedè
Mar 9, 2010·Seminars in Cancer Biology·Alice Machado-SilvaJean-Christophe Bourdon
May 13, 2008·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E MammanoD Nitti
Apr 30, 2008·Journal of Cellular Biochemistry·Tiffany E FarmerScott W Hiebert
Oct 8, 2009·International Journal of Cancer. Journal International Du Cancer·Toshiji TominagaHiroki Yamaue
Apr 26, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chaar InesBouraoui Saadia
Sep 6, 2012·Journal of Zhejiang University. Science. B·Wei-qin JiangLi-song Teng
Aug 11, 2012·Biochemical and Biophysical Research Communications·Anastasia-Evi HandayaningsihYutaka Takahashi
Jan 19, 2013·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Ibrahim SariAbdullah T Demiryurek
Jun 23, 2012·Digestive Diseases·Alberto Malesci, Luigi Laghi
Mar 8, 2017·Journal of Biomolecular Structure & Dynamics·Mahalakshmi RVijayalakshmi Mahadevan
Jan 1, 2011·Cancers·Paolo BianchiAlberto Malesci
Jul 20, 2007·British Journal of Cancer·J-C Bourdon
Sep 18, 2015·Korean Journal of Hepato-biliary-pancreatic Surgery·Doo-Ho LeeHae Won Lee
Dec 18, 2007·Journal of Surgical Oncology·Matthew G Mutch
Feb 28, 2019·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Yuewen QiBingqing Li
Jan 7, 2015·World Journal of Gastroenterology : WJG·Xiao-Li WeiRui-Hua Xu
Jan 13, 2015·World Journal of Gastroenterology : WJG·Xiao-Lan LiWee-Joo Chng
Jul 14, 2019·Proceedings of the National Academy of Sciences of the United States of America·Haruna TakedaMasanobu Oshima
Mar 11, 2020·Frontiers in Genetics·Xiang DingHesheng Luo
Feb 13, 2018·World Journal of Gastroenterology : WJG·A-Jian LiLu Yin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.